T0	Interventions 211 218	(TGF-Î²)
T1	Interventions 345 346	.
T2	Interventions 347 380	TGF-beta receptor type-2 (TGFBR2)
T3	Interventions 606 626	randomised tamoxifen
T4	Interventions 694 709	examined TGFBR2
T5	Interventions 769 790	target SMAD2 (pSMAD2)
T6	Interventions 799 838	in cancer-associated fibroblasts (CAFs)
T7	Interventions 1748 1759	transfected
T8	Interventions 1782 1786	with